Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: Heat Shock who wrote (233)	4/14/2005 7:45:56 PM
From: Heat Shock	Respond to of 236

To all, 2 Press Releases today: Stressgen announces sale of bioreagents business for approximately C$8.0 million and withdraws preliminary prospectus for offering of common shares newswire.ca Stressgen announces appointment of new President and Chief Executive Officer newswire.ca I have no particular opinion of the departing CEO, but BioGold on stockhouse.ca (Post #9496906) said the following: << This guy has been terrible for Stressgen. I had two long conversations with him several years ago. Totally Pathetic, but I have always liked the technology. I don't know anything about Greg McKee, but at least he is a finance guy, and hopefully he will get this burn rate cut quickly, get the reagents business sold and make a real effort to show the investment community the promise of HspE7 and the overall vaccine technology, which should certainly help this pathetic stock price. I have complained about Korpolinski for years, thank goodness he is gone. This could be a new beginning for Stressgen. McKee has his work cut out for him, the company is in a deep hole, Korpie about destroyed it, but I think there is hope. I still like the technology. May buy a few shares tomorrow. B G >> Heat